To explore the potential role of MEX3A in BC, we first carried out analyses of non-matched and matched tumor and normal samples in TCGA databases, and found MEX3A was significantly overexpression in BC samples (Fig. 1A, B). This evidence concerns the gene MEX3A and breast cancer.